Description
Schedule of activities for offer to buy acquisition window (takeover) of PHARMAIDS PHARMACEUTICALS LTD shares from August 4-18, 2025.
Summary
BSE announces the schedule for Offer to Buy – Acquisition Window (Takeover) for PHARMAIDS PHARMACEUTICALS LTD shares. The offer will run from Monday, August 4, 2025 to Monday, August 18, 2025, targeting up to 91,69,632 equity shares at Rs. 62.15 per share.
Key Points
- Security: PHARMAIDS PHARMACEUTICALS LTD (Symbol: PHARMAID, ISIN: INE117D01018, Scrip Code: 524572)
- Offer size: Up to 91,69,632 equity shares
- Offer price: Rs. 62.15 per share
- Face value: Rs. 10.00
- Market lot: 1 share
- Offer period: August 4-18, 2025
Session Timings
- Bid Offering Period: August 4-18, 2025 (9:15 AM to 3:30 PM)
- Give-up/Take-up: August 4-14, 2025 (9:15 AM to 3:30 PM)
- Give-up (last day): August 18, 2025 (9:15 AM to 3:30 PM)
- Take-up (last day): August 18, 2025 (9:15 AM to 4:00 PM)
Trading Categories
- Foreign Institutional Buyer (FII)
- Financial Institution (FI)
- Mutual Fund (MF)
- Insurance Companies (IC)
- Other QIBs (OTH)
- Other NIB (NOH)
- Company (CO)
- Individual (IND)
Platform Access URLs
- iBBS Internet: https://ibbs.bseindia.com/
- iBBS Leased Line: https://ibbsll.bseindia.com/
- RTRMS Internet: https://rtrms.bseindia.com/
- RTRMS Leased Line: https://rtrmsll.bseindia.com/
- Member Extranet Internet: https://member.bseindia.com/
- Member Extranet Leased Line: https://memberll.bseindia.com/
Compliance Requirements
- Trading members must ensure UCC of investors is registered with correct PAN number and category
- Members can only bid for investors having shares in demat form
- Files on Extranet for bid acceptance available after confirmation from Merchant Banker/RTA
- No End of Issue files generated if no securities are accepted
Important Dates
- Opening Date: Monday, August 4, 2025
- Closing Date: Monday, August 18, 2025
- Give-up deadline: August 14, 2025
- Final take-up: August 18, 2025 (extended to 4:00 PM)
Impact Assessment
This takeover offer affects PHARMAIDS PHARMACEUTICALS LTD shareholders and provides an exit opportunity at Rs. 62.15 per share. Trading members need to prepare systems and ensure compliance with UCC requirements. The 15-day offer window provides adequate time for participation across various investor categories.
Impact Justification
Corporate action affecting specific stock with defined timeline and procedures